# Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant

> **NCT01239472** · PHASE4 · COMPLETED · sponsor: **Andre Barreto Pereira** · enrollment: 30 (actual)

## Conditions studied

- Renal Transplant Rejection
- Immunosuppression

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT01239472
- **Lead sponsor:** Andre Barreto Pereira
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01239472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01239472, "Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01239472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*